Max Arella, Ph.D
Chief Scientific Officer
An accomplished biotech & pharma entrepreneur, Dr. Arella has extensive experience in novel drug discovery, technology development and transfer in pharmaceutical industry, as well commercialization in the biotechnology and life sciences space. Dr. Arella received his PhD from the Institut Armand-Frappier/Université du Québec in collaboration with Université de Rouen. He completed his postdoctoral research in Biotechnology from the Roche Institute of Molecular Biology.